Product Image

NeuroIGNITE

Havasu Nutrition
4.0
★ ★ ★ ★ ★
(8592 ratings)
Acetyl L-Carnitine 50 mg
Deanol 50 mg
Bacopa 300 mg
Ginkgo
St. John's Wort 130 mg
Product Image
Score72
Bacopa gives the formula a useful core, but the other nootropics are modest and Saint John’s wort creates major interaction concerns. Convenience does not offset the narrow safety fit.
How scoring works
Quantity:30 Capsule(s) • (30 servings)
Goals:
Brain Health
Mental Focus

Score 72

Bacopa gives the formula a useful core, but the other nootropics are modest and Saint John’s wort creates major interaction concerns. Convenience does not offset the narrow safety fit.
How scoring works
$19.99($0.66 per serving)
Pure Formulas
$ 22.39
iHerb
$ 22.39
Walmart
$ 22.39
Amazon
$ 19.99
iHerb
$ 22.39
Vitacost
$ 22.39
Report prices

Analysis

The formula combines 300 mg of bacopa with Saint John’s wort, DMAE bitartrate, ginkgo, phosphatidylserine, acetyl-L-carnitine, and a small huperzine A amount. Bacopa is the main long-term memory ingredient, although its bacoside percentage is not stated.

Acetyl-L-carnitine, ginkgo, phosphatidylserine, DMAE, and huperzine A are all modest for focused supplementation. Saint John’s wort also lacks a hypericin percentage and has a much broader interaction profile than the rest of the formula.

One capsule and moderate cost make the product easy to take. Medication screening is essential, and many users will be better served by a cognitive formula without Saint John’s wort.

Who is it for
  • Adults not using interacting medicines who specifically want bacopa with Saint John’s wort
  • Users who prefer one capsule
  • People who have reviewed the formula with a pharmacist or clinician
Best for
  • Bacopa-centered cognitive support
  • A compact one-capsule nootropic
  • Users specifically seeking a mood-and-focus blend after interaction screening

Pros

  • Provides 300 mg of bacopa extract
  • Uses a one-capsule serving
  • Includes several cognitive pathways
  • Clearly lists individual ingredient amounts

Cons

  • Bacopa standardization percentage is missing
  • Most supporting nootropics are lightly dosed
  • Saint John’s wort potency is unclear
  • The interaction burden is unusually high
  • Huperzine A is only lightly represented

Warnings

  • Saint John’s wort can reduce the effectiveness of hormonal contraceptives, warfarin, transplant medicines, seizure medicines, HIV medicines, and many other drugs.
  • Do not combine Saint John’s wort with SSRIs, SNRIs, MAO inhibitors, or other serotonergic medicines without prescriber guidance because serotonin-related toxicity can occur.
  • Saint John’s wort may increase sun sensitivity.
  • Ginkgo may add bleeding risk with anticoagulant or antiplatelet medicines.

Nutrient quality

71 High impact

Standardized bacopa, ginkgo, and Saint John’s wort extracts are identified, though several forms lack fuller detail. Bacopa has a useful amount, while acetyl-L-carnitine, ginkgo, phosphatidylserine, DMAE, and huperzine A are comparatively light.

Ingredient transparency

74 High impact

Every listed active has a specific quantity. Capsule materials and other inactive ingredients are not shown.

Customer satisfaction

63 Moderate impact

The supplied aggregate rating is only moderately favorable and provides no experience details. No specific feedback is supplied, so recurring complaints cannot be assessed.

Value for money

77 High impact

The accessible cost is reasonable for a focused blend, though several key ingredients are lightly dosed. The serving cost is moderate for the number of disclosed actives.

Report analysis

Goals

Brain Health
Brain Health
Impact
High effect
A- Goal FitC- Strength of SupportB+ CoverageB+ Formula Quality
Bacopa · 300 mg

Bacopa, phosphatidylserine, ginkgo, acetyl L-carnitine, and huperzine create a clearly brain-focused formula. Bacopa reaches a commonly used extract amount, but missing active-marker percentages make its true potency uncertain.

Several supporting ingredients are underdosed, so the broad label offers more coverage than depth. Saint John’s wort can reduce the effectiveness of hormonal contraceptives and many medicines and can increase serotonin-related risk with antidepressants.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Mental Focus
Mental Focus
Impact
High effect
B+ Goal FitC Strength of SupportB- CoverageC- Formula Quality
Acetyl L-Carnitine · 50 mg

Bacopa is supplied at a commonly used extract amount and provides the strongest evidence for memory and processing support. Ginkgo, phosphatidylserine, acetyl-L-carnitine, DMAE, and huperzine broaden the cognitive profile.

Most supporting nootropics are underdosed, and bacoside strength is not stated, creating a kitchen-sink formula with uneven depth. Saint John's wort can reduce the effectiveness of hormonal contraceptives and many medicines and can raise serotonin-related risk with antidepressants.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Stress Relief
Stress Relief
Impact
Moderate effect
C+ Goal FitC+ Strength of SupportC- CoverageC Formula Quality

Bacopa may support cognitive stress resilience, while phosphatidylserine offers a modest secondary pathway. The bacopa amount is substantial enough to be relevant if the extract is appropriately standardized.

St. John’s wort and several cognitive ingredients complicate the formula without clear calming depth. St. John’s wort has major interaction potential with many medicines, including antidepressants and hormonal contraceptives.

Study evidence
Bacopa Supportive 8 studies
St. John's Wort Mixed 6 studies
Cognitive Support
Cognitive Support
Impact
Moderate effect
B Goal FitD Strength of SupportB- CoverageC Formula Quality
Acetyl L-Carnitine · 50 mgBacopa · 300 mg

Bacopa provides the strongest cognitive anchor, with ginkgo, phosphatidylserine, acetyl-L-carnitine, DMAE, and huperzine A adding several mechanisms. The stack targets memory, circulation, acetylcholine, and cellular energy.

Most supporting ingredients are far below typical standalone amounts, and Bacopa standardization is incomplete. Saint John’s wort can reduce the effectiveness of hormonal contraceptives and many medicines and can raise serotonin-related risk with antidepressants.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Productivity Boost
Productivity Boost
Impact
Moderate effect
B+ Goal FitD+ Strength of SupportC+ CoverageD+ Formula Quality
Acetyl L-Carnitine · 50 mgAcetyl L-Carnitine · 50 mg

Bacopa provides a credible long-term memory pathway within a broadly nootropic formula. Ginkgo, phosphatidylserine, acetyl L-carnitine, and huperzine add logical mechanisms but appear underdosed.

St. John’s wort can interact with antidepressants, hormonal contraceptives, anticoagulants, and many other medicines by changing drug metabolism. Medication interactions deserve careful review before use, and the product is better suited to long-term memory support than immediate focus.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mood Support
Mood Support
Impact
Moderate effect
B- Goal FitF Strength of SupportC CoverageB- Formula Quality

Saint John’s wort gives the formula direct mood relevance, while bacopa, ginkgo, and phosphatidylserine broaden brain support. The main Saint John’s wort amount is low, and its active marker is not quantified.

Bacopa reaches a useful extract amount, but missing standardization makes potency uncertain across the botanical blend. Saint John’s wort can interact with antidepressants and may reduce the effects of oral contraceptives or anticoagulants.

Study evidence
Bacopa Supportive 7 studies
St. John's Wort Supportive 97 studies

Ingredients

IngredientAmount per serving
Bacopa monnieri extract (Bacosides)
 300 mg
St. John's Wort extract (Hypercins)
 130 mg
Dimethylaminoethanol (Dimethylaminoethanol Bitartrate)
 50 mg
Ginkgo biloba extract (Flavone Glycosides)
 50 mg
Phosphatidylserine
50 mg
Acetyl L-Carnitine HCl
50 mg
Huperzine A (Huperzia serrata extract)
 10 mcg
Adults 18–50
Report overview
Acetyl L-Carnitine · 50 mg OverallScore55
A- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

The 50 mg ALCAR hydrochloride amount is clearly disclosed but too small to make this a practical ALCAR supplement. Bacopa and the other cognitive ingredients add breadth, yet they do not offset the weak ALCAR value. St. John's wort can reduce the effectiveness of hormonal contraceptives and many other medicines and can raise serotonin-related risk with antidepressants.

View ingredientView products
Deanol (Dimethylaminoethanol Bitartrate) · 50 mg OverallScore48
B- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

DMAE bitartrate is clearly identified, but the label does not state how much active Deanol it yields. The listed salt amount supplies about 18.5 mg active Deanol, leaving the dose quite low for focused supplementation. One capsule is convenient, but St. John's wort may interact with antidepressants and hormonal contraceptives.

View ingredientView products
Bacopa (Bacosides) · 300 mg OverallScore34
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyF Value

Bacosides are named, but the missing percentage prevents a reliable potency calculation. No trademarked or clinically identified extract is named. The label names Bacopa monnieri but does not identify the plant part. The 300 mg extract amount is well aligned with the established extract range, while the serving cost is difficult to justify without a verified high-potency extract. The included 130 mg St. John's wort extract can interact with antidepressants and hormonal contraceptives.

View ingredientView products
Loading alternative details
76 Performance

Ultimate Neuro Complex

Natural Factors 3 Brains
<p>Acetyl-L-carnitine, NAC, alpha-lipoic acid, and huperzine A lead a well-chosen cognitive formula, giving it a more focused ingredient profile than NeuroIGNITE. Vinpocetine and huperzine A call for extra caution with medicines and sensitivity.</p>
75 Performance

Brain Cell Support

Metabolic Maintenance
<p>Acetyl-L-carnitine, Cognizin citicoline, phosphatidylserine, ginkgo, and gotu kola are provided at generally useful amounts, giving it a more focused ingredient profile than NeuroIGNITE. Repeated extract entries make some quantities ambiguous.</p>
73 Performance

Neuro-Peak

ZHOU
<p>Meaningful bacopa and ginkgo amounts are paired with methylcobalamin in a focused cognitive blend, giving it a more focused ingredient profile than NeuroIGNITE. The stated huperzine amount is aggressive for routine use.</p>
76 Budget

Pure Brainpower

Swanson
<p>The lower serving cost makes Pure Brainpower a more economical alternative to NeuroIGNITE. A clinically aligned Bacognize amount is paired with ginkgo and coffee-fruit extract. Active-marker and excipient details remain incomplete.</p>
78 Budget

Ginkgo+

NS Natural Stacks
<p>The lower serving cost makes Ginkgo+ a more economical alternative to NeuroIGNITE. Useful ginseng, bacopa, and ginkgo amounts form a coherent cognitive blend. Active-marker percentages and ginkgo purity details are missing.</p>
77 Budget

Memory Complex

Natrol
<p>The lower serving cost makes Memory Complex a more economical alternative to NeuroIGNITE. Bacopa, ginkgo, B vitamins, and huperzine A provide a broader memory-focused core. Extract-marker details are incomplete, and ginkgo can interact with anticoagulant or antiplatelet medicines.</p>
57 Value

Think Support

Zoi Research
<p>Recognized bacopa and substantial ginkgo amounts provide a focused alternative without St. John’s wort, while a lower serving cost improves practical value relative to NeuroIGNITE. Several proprietary blends leave potency and formula value uncertain.</p>
62 Value

Ginkgo Smart

Irwin Naturals
<p>Standardized ginkgo and fish oil provide a more focused cognitive base without St. John’s wort, while a lower serving cost improves practical value relative to NeuroIGNITE. Most supporting actives are modest, and the clubmoss active is not quantified.</p>
57 Value

ThinkFast

Futurebiotics
<p>Recognized bacopa and substantial ginkgo amounts provide a relevant cognitive core, while a comparable serving cost improves practical value relative to NeuroIGNITE. Hidden blends and incomplete extract standards weaken transparency.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledBrain Health Cognitive Support Mental Focus forBacopa
  2. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.
    Nathan PJ; Clarke J; Lloyd J; Hutchison CW; Downey L; Stough C · Human psychopharmacology · 2019
    Randomized trial38 participantsBrain Health Cognitive Support forBacopa
  3. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  4. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  5. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  6. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  7. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  8. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  9. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  10. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  11. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  12. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledBrain Health Cognitive Support forBacopa
  13. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  14. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  15. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  16. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  17. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  18. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  19. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  20. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  21. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  22. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  23. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  24. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  25. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  26. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  27. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  28. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  29. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  30. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus forBacopa
  31. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  32. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewMental Focus forBacopa
  33. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  34. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  35. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  36. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  37. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  38. The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lopresti AL; Smith SJ · Clinical drug investigation · 2025
    Randomized trial101 participantsMood Support forBacopa
  39. Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.
    Kean JD; Downey LA; Sarris J; Kaufman J; Zangara A; Stough C · Phytotherapy research : PTR · 2022
    Randomized trial112 participantsMood Support forBacopa
  40. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects.
    Stough C; Lloyd J; Clarke J; Downey LA; Hutchison CW; Rodgers T; Nathan PJ · Psychopharmacology · 2001
    Randomized trial85 participantsMood Support Stress Relief forBacopa
  41. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsMood Support Productivity Boost Stress Relief forBacopa
  42. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
    Sathyanarayanan V; Thomas T; Einöther SJ; Dobriyal R; Joshi MK; Krishnamachari S · Psychopharmacology · 2013
    Randomized trial72 participantsMood Support forBacopa
  43. St John's wort for major depression.
    Linde K; Berner MM; Kriston L · The Cochrane database of systematic reviews · 2009
    Systematic review5,489 participants29 studies pooledMood Support forSt. John's Wort
  44. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M · The American journal of psychiatry · 2002
    Randomized trial375 participantsMood Support forSt. John's Wort
  45. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
    Whiskey E; Werneke U; Taylor D · International clinical psychopharmacology · 2002
    Meta-analysis22 studies pooledMood Support forSt. John's Wort
  46. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M · Pharmacopsychiatry · 2001
    Randomized trial72 participantsMood Support forSt. John's Wort
  47. Complementary therapies for clinical depression: an overview of systematic reviews.
    Haller H; Anheyer D; Cramer H; Dobos G · BMJ open · 2020
    Systematic review26 studies pooledMood Support forSt. John's Wort
  48. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  49. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  50. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  51. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  52. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  53. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  54. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  55. Efficacy of Brahmi vati in generalised anxiety disorder - Randomized double blind comparative clinical trial.
    Khot SG; Tubaki BR; Gonugade VB · Journal of Ayurveda and integrative medicine · 2022
    Randomized trial56 participantsStress Relief forBacopa
  56. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.
    Benson S; Downey LA; Stough C; Wetherell M; Zangara A; Scholey A · Phytotherapy research : PTR · 2014
    Randomized trial17 participantsStress Relief forBacopa
  57. Herbal remedies for anxiety - a systematic review of controlled clinical trials.
    Ernst E · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2006
    Systematic review8 studies pooledStress Relief forBacopa
  58. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
    Woelk H · BMJ (Clinical research ed.) · 2000
    Randomized trial324 participantsStress Relief forSt. John's Wort
  59. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
    Friede M; Henneicke von Zepelin HH; Freudenstein J · Pharmacopsychiatry · 2002
    Randomized trial240 participantsStress Relief forSt. John's Wort
  60. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Systematic reviewStress Relief forSt. John's Wort
  61. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
    Bitran S; Farabaugh AH; Ameral VE; LaRocca RA; Clain AJ; Fava M; Mischoulon D · International clinical psychopharmacology · 2012
    Other475 participantsStress Relief forSt. John's Wort
  62. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.
    Lakhan SE; Vieira KF · Nutrition journal · 2011
    Systematic review2,619 participants24 studies pooledStress Relief forSt. John's Wort